The first KCL event of 2012 for the Oxbridge Biotech Roundtable will be held on January 19th, where serial entrepreneur Dr Yen Choo (of Plasticell and Progenitor Labs Ltd) will share his experience and provide advice to budding entrepreneurs. This is a fantastic opportunity to learn a great amount about bioentrepreneurship as well as meeting the OBR team members to experience first-hand what OBR is all about.
Oxbridge Biotech Roundtable (OBR) is a network of students, academics and professionals from across disciplines such as science, business, medicine and law. The objective of OBR is to connect industry and academia fostering biotech innovation and commercialization. It provides exposure to young idea-holders from across the UK both with one another, and with industry resources needed to move their ideas forward. Especially, OBR seeks to tear down barriers between people interested in the life sciences industry.
Funded in summer 2011, the organization is rapidly expanding and already has over 2000 members from Imperial, UCL, Kings, MRC, UCL, Cambridge and Oxford. In addition, other London-based universities such as Queen Mary University, ICR will be new collaborators of OBR in the near future. As a student community, the organisation is offering numerous opportunities to collaborate and learn through our online publications, business development workshop and speaker series. At each of our affiliated institutions, visionary leaders from biotech, pharma, finance, law, and entrepreneurship share their insight with students, post docs and young academics. The brilliant idea of OBR is to build a wide network and engages members via a three-pronged approaches:
- Education: Offering various seminars, workshops, panel discussions and networking opportunities with unique industry perspective
- Industry Immersion: Providing industry internships to allow exposure of young motivated and talented Oxbridge students to industry partners
- Communication: The OBR online blog, the roundtable review, promotes communication between campuses across geographies
To provide students a practical opportunity/workshop to get involved in phama business, KCL is organising on February 24th in collaboration with the management consulting firm Catenion, a strategy board game for students to explore and challenge their business knowledge/skills.
Since OBR is just at the beginning of their activities in London, the organisation is continuously seeking for novel additions to the existing portfolio of partners, which includes amongst others the technology transfer offices Imperial Innovations and Isis Innovation, the b-2-b networks OneNucleus and OBN, as well as a range of biotech companies such as Oxford Nanopore Technology. OBR is keen to expand their network at KCL and is open to motivated and talented students who want to make a tremendous impact on the life sciences. Students who want to contribute to OBR in any area reaching from business development, through events management to consulting are welcome to contact the OBR team at KCL.
Upcoming OBR-London events:
How IP turns scientific breakthroughs into profitable ventures (Feb 9)
Risky Business: The Pharma Game (Feb 21, 22, 24)
The biotech debate: “This house believes UK biotech is dead” (Mar 16)
Discussion
Comments are closed.